Co-Diagnostics, Other Wednesday, September 16, 2026 0.00 Neutral

Co-Dx and ReadyGo collaborate to evaluate blood-based point-of-need testing

Co-Diagnostics and ReadyGo are collaborating to evaluate ReadyGo's blood sample prep technology with Co-Dx PCR platform for decentralized Ebola detection, potentially expanding the platform to other bloodborne pathogens like HIV and Hepatitis.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day